Human cancers commonly delete P16 and/or P15 to overcome growth inhibition, yet the rBH3-containing member, P18, whose expression has been shown to compensate for loss of P16, is rarely deleted24 (Supplementary Fig. S2). This evidence concerns the gene CDKN2C and cancer.